🇺🇸 FDA
Patent

US 9884100

Lutzomyia longipalpis polypeptides and methods of use

granted A61KA61K2039/53A61K2039/57

Quick answer

US patent 9884100 (Lutzomyia longipalpis polypeptides and methods of use) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Feb 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/53, A61K2039/57, A61K2039/575, A61K2039/58